Correlation Between NCR Atleos and Aquestive Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NCR Atleos and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NCR Atleos and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NCR Atleos and Aquestive Therapeutics, you can compare the effects of market volatilities on NCR Atleos and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NCR Atleos with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NCR Atleos and Aquestive Therapeutics.

Diversification Opportunities for NCR Atleos and Aquestive Therapeutics

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between NCR and Aquestive is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding NCR Atleos and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and NCR Atleos is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NCR Atleos are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of NCR Atleos i.e., NCR Atleos and Aquestive Therapeutics go up and down completely randomly.

Pair Corralation between NCR Atleos and Aquestive Therapeutics

Given the investment horizon of 90 days NCR Atleos is expected to generate 0.57 times more return on investment than Aquestive Therapeutics. However, NCR Atleos is 1.76 times less risky than Aquestive Therapeutics. It trades about 0.42 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about -0.06 per unit of risk. If you would invest  2,622  in NCR Atleos on September 2, 2024 and sell it today you would earn a total of  659.00  from holding NCR Atleos or generate 25.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

NCR Atleos  vs.  Aquestive Therapeutics

 Performance 
       Timeline  
NCR Atleos 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in NCR Atleos are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain basic indicators, NCR Atleos disclosed solid returns over the last few months and may actually be approaching a breakup point.
Aquestive Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Aquestive Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

NCR Atleos and Aquestive Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NCR Atleos and Aquestive Therapeutics

The main advantage of trading using opposite NCR Atleos and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NCR Atleos position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.
The idea behind NCR Atleos and Aquestive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Directory
Find actively traded commodities issued by global exchanges